Veltio Pharma Welcomes Jens Landström as CSO

Veltio Pharma is pleased to welcome Jens Landström as Chief Scientific Officer (CSO). Jens brings over 15 years of pharmaceutical R&D experience, from discovery to clinic, with deep expertise in bioavailability enhancement of poorly soluble APIs, solid-state characterization, dissolution optimization, and CMC strategy.

"We are delighted to strengthen our team with Jens, his expertise will be important for the company's future development," says Stina Lundgren, CEO of Veltio Pharma.

Jens's addition strengthens our mission to developing better pharmaceuticals, both in performance and sustainability.